Stephan Toutain

Chief Operating Officer at ANAVEX LIFE SCIENCES CORP.

Health Technology

Consumer Services

Profile

Stephan Toutain is currently the Senior Vice President-Operations at Anavex Life Sciences Corp.
He previously worked as the General Manager at Alexion Pharmaceuticals, Inc. from 2009 to 2011, Head-Global Commercial Development at Sarepta Therapeutics, Inc. from 2014 to 2015, and Chief Commercial Officer at Interleukin Genetics, Inc. from 2016 to 2017.
He has a graduate degree from Nancy-Université and an MBA from The University of North Carolina at Charlotte.

Stephan Toutain active positions

Companies	Position	Start
ANAVEX LIFE SCIENCES CORP.	Chief Operating Officer	2018-03-04

All active positions of Stephan Toutain

Former positions of Stephan Toutain

Companies	Position	End
INTERLEUKIN GENETICS, INC	Corporate Officer/Principal	2017-07-31
SAREPTA THERAPEUTICS, INC.	Corporate Officer/Principal	2014-12-31
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	2010-12-31

See the detail of Stephan Toutain's experience

Training of Stephan Toutain

Nancy-Université	Graduate Degree
The University of North Carolina at Charlotte	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephan Toutain's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SAREPTA THERAPEUTICS, INC.	Health Technology
ANAVEX LIFE SCIENCES CORP.	Health Technology

Private companies	2
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Interleukin Genetics, Inc. Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA.	Health Technology

Private companies